id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-337738-2qck1j1w	Martin, Jennifer H.	Buying time: Drug repurposing to treat the host in COVID‐19H	2020-06-23		.txt	text/plain	1475	79	43	COVID19, drug repurposing, global collaboration, host response, renin-angiotensin 2 of 3 | COMMENTARY a further 1-5 years to complete necessary studies, and finalise the regulatory pharmaceutics dossier, but even then, time is still needed to find funding to manufacture, upscale, and develop supply lines to roll it out globally. An approach based on treating the host built on sound physiology and pathophysiology, together with thorough administrative data input and accepted principles of drug repurposing based upon pharmacology and clinical pharmacology is needed. • An international approach to rapidly identify drugs that treat the host in a pandemic to permit time for vaccine and antiviral development. 12 Such a program can provide adequate time for the development of vaccines, serum-based approaches or antiviral drugs, and separately will provide a therapeutic insurance with the inevitable easing of social isolation. Buying time: Drug repurposing to treat the host in COVID-19H	./cache/cord-337738-2qck1j1w.txt	./txt/cord-337738-2qck1j1w.txt